Junli W. Mou

State Key Laboratory Of Experimental Hematology, Chinese Academy Of Medical Sciences & Peking Union Medical College
Tianjin, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Correction: Regulatory T cells promote the stemness of leukemia stem cells through IL10 cytokine-related signaling pathway.

Correction: Regulatory T cells promote the stemness of leukemia stem cells through IL10 cytokine-related signaling pathway.

Journal: Leukemia

Published: April 15, 2025

Activating innate immune responses repolarizes hPSC-derived CAR macrophages to improve anti-tumor activity.

Activating innate immune responses repolarizes hPSC-derived CAR macrophages to improve anti-tumor activity.

Journal: Cell stem cell

Published: April 11, 2025

Single-cell transcriptome profiling reveals blast cell heterogeneity and identifies novel therapeutic target IKZF2 in t(8;21) acute myeloid leukaemia.

Single-cell transcriptome profiling reveals blast cell heterogeneity and identifies novel therapeutic target IKZF2 in t(8;21) acute myeloid leukaemia.

Journal: British journal of haematology

Published: December 24, 2024

AML1-ETO and CCND2 overexpression cooperate to drive acute myeloid leukemia initiation and progression.

AML1-ETO and CCND2 overexpression cooperate to drive acute myeloid leukemia initiation and progression.

Journal: Journal of leukocyte biology

Published: November 17, 2024

Identifying ADGRG1 as a specific marker for tumor-reactive T cells in acute myeloid leukemia.

Identifying ADGRG1 as a specific marker for tumor-reactive T cells in acute myeloid leukemia.

Journal: Experimental hematology & oncology

Published: June 26, 2024

Targeting Fatty Acid Metabolism Abrogates the Differentiation Blockade in Preleukemic Cells.

Targeting Fatty Acid Metabolism Abrogates the Differentiation Blockade in Preleukemic Cells.

Journal: Cancer research

Published: January 12, 2024

Universal Anti-CD7 CAR-T Cells Targeting T-ALL and Functional Analysis of CD7 Antigen on T/CAR-T Cells.

Universal Anti-CD7 CAR-T Cells Targeting T-ALL and Functional Analysis of CD7 Antigen on T/CAR-T Cells.

Journal: Human gene therapy

Published: October 20, 2023

Activating innate immune responses repolarizes hPSC-derived CAR macrophages to improve anti-tumor activity.

Activating innate immune responses repolarizes hPSC-derived CAR macrophages to improve anti-tumor activity.

Journal: Cell stem cell

Published: July 31, 2023

Construction of CD19 targeted dual- and enhanced dual-antibodies and their efficiency in the treatment of B cell malignancy.

Construction of CD19 targeted dual- and enhanced dual-antibodies and their efficiency in the treatment of B cell malignancy.

Journal: Experimental hematology & oncology

Published: March 29, 2023

2B4 inhibits the apoptosis of natural killer cells through phosphorylated extracellular signal-related kinase/B-cell lymphoma 2 signal pathway.

2B4 inhibits the apoptosis of natural killer cells through phosphorylated extracellular signal-related kinase/B-cell lymphoma 2 signal pathway.

Journal: Cytotherapy

Published: February 02, 2023

Novel CD123×CD33 bicistronic chimeric antigen receptor (CAR)-T therapy has potential to reduce escape from single-target CAR-T with no more hematotoxicity.

Novel CD123×CD33 bicistronic chimeric antigen receptor (CAR)-T therapy has potential to reduce escape from single-target CAR-T with no more hematotoxicity.

Journal: Cancer communications (London, England)

Published: January 27, 2023

Correction: Targeting of IL-10R on acute myeloid leukemia blasts with chimeric antigen receptor-expressing T cells.

Correction: Targeting of IL-10R on acute myeloid leukemia blasts with chimeric antigen receptor-expressing T cells.

Journal: Blood cancer journal

Published: March 17, 2022

Showing 1-12 of 17

Last Updated: 09/26/2026